---
title: "Gilead Sciences CFO Sells Over $14 Million in Company Stock"
date: "2025-02-14 10:20:01"
summary: "Reporter NameDickinson Andrew DRelationshipChief Financial OfficerTypeSellAmount$14,073,240SEC FilingForm 4Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences, sold 137,676 shares of common stock on February 12, 2025, at a price of $102.22 per share, totaling $14,073,240. Following this transaction, Dickinson directly owns 171,223 shares of Gilead Sciences. The sale was conducted..."
categories:
  - "TradingView"
lang:
  - "en"
translations:
  - "en"
tags:
  - "TradingView"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

| Reporter Name | Dickinson Andrew D |
| --- | --- |
| Relationship | Chief Financial Officer |
| Type | Sell |
| Amount | $14,073,240 |
| SEC Filing | [Form 4](https://www.sec.gov/Archives/edgar/data/1310204/000112760225004784/xslF345X05/form4.xml) |

Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences, sold 137,676 shares of common stock on February 12, 2025, at a price of $102.22 per share, totaling $14,073,240. Following this transaction, Dickinson directly owns 171,223 shares of Gilead Sciences. The sale was conducted under a Rule 10b5-1 trading plan adopted on August 29, 2024.

SEC Filing: [GILEAD SCIENCES, INC. [ GILD ] - Form 4 - Feb. 13, 2025](https://www.sec.gov/Archives/edgar/data/1310204/000112760225004784/xslF345X05/form4.xml)

[TradingView](https://www.tradingview.com/news/tradingview:970036b034adb:0-gilead-sciences-cfo-sells-over-14-million-in-company-stock/)
